A Comprehensive Review on Microspheres

Controlled release Oral dosage form deliver the drug in the gastrointestinal (GI) tract at a rate that is controlled by the type of physiological processes of the alimentary canal. (Chu & Traverso, 2022) (Procopio et al., 2022). There is a growing interest in the development of homogeneous monolithic drug release system for various route of administration.(Namdev & Jain, 2019). (Ravindra et al., 2026). (Goyal et al., 2019)This change results unknown bioavalibility of the oral forms.Microspheres are tiny spherical particles with dimensions ranging from micrometers to (usually between 1um and 1000um). Microparticlesare another name for microspheres (Adepu & Ramakrishna, 2021a; Goyal et al., 2019). Numerous synthetic and natural materials can be used to create microspheres.There are three types of commercially accessible microspheres : glass, polymer, and ceramic. Because of their vastly varied densities,solid and hollow microspheres have various uses.

DEFINITION:

Microspheres are in certain cases they are also referred to as microparticles. They consist of biodegradable proteins or synthetic materials. polymers. (Noguez Méndez et al., 2017)

CRITERIA FOR MICROSPHERE PREPARATION:

The selection of microsphere production techniques requires consideration of various elements which include target particle dimensions and administration path and drug release period and mixing velocity and cross-linking type and solvent evaporation duration and co-precipitation settings (Ravindra et al., 2026). To achieve an effective microsphere formulation, the preparation should meet the following essential criteria: The system needs to store large amounts of active pharmaceutical ingredient (API) during encapsulation (GALASKA & RICHEY, 2022). The formulation must exhibit adequate stability after synthesis, ensuring a clinically acceptable shelf life (Chauhan et al., 2021). The injectable microspheres need to have both consistent particle size distribution and excellent water-based dispersion characteristics (Wang et al., 2024). The system needs to deliver controlled active compound release throughout its designated operational timeframe (Adepu & Ramakrishna, 2021b). The material needs to support biocompatibility through its ability to modify degradation speed (Hussain et al., 2024). The polymer matrix demands functional control through chemical transformation to achieve its ideal operational systems (Dobrotă et al., 2025).

TYPES OF MICROSPHERES:

1. Bioadhesive microspheres (Aqueel et al., n.d.)

2. Magnetic microspheres (N et al., 2026)

3. Radioactive microspheres (Sinha et al., 2004)

4. Floating microspheres (BHISE et al., 2022)

5. Polymeric microspheres (Saralidze et al., 2010a)

6. Biodegradable polymeric microspheres (Moritera et al., 1991)

7. Synthetic polymeric microspheres (Saralidze et al., 2010b)

1.Bioadhesive microspheres

Bioadherence can be defined as adhesion to the mucosal membrane of the drug delivery device, including the buccal, ocular, rectal, nasal, and other similar routes. These types of microspheres show a extended stay at the application site, elicit close contact with the absorption site, and produce improved therapeutic Results. Mucoadhesive microspheres help the drug stick to the mucosal surface. This means the drug stays where it is needed for a longer time. The drug can work better and the body can take in more of it. This way, you may also need to take the medicine less often. contact and offer prolonged contact time at the The place where the application or absorption takes place. The underlying surface where absorption is anticipated to take This causes the drug to have a greater therapeutic effectiveness.

2. Magnetic microspheres:

Microspheres are typically free-moving, tiny, spherical particles with a size range of 1–1000 μm that are made of proteins or synthetic polymers and are biodegradable; they are considered one of the most important methods for safely Giving medicines for therapeutic purposes. and regulated A means of delivering it to the desired location.

The various kinds of

a) Therapeutic magnetic microspheres: renowned for treating liver tumors with Chemotherapy; medicinal items such as proteins and This technology can also act on peptides.

b) Diagnostic Microspheres: By producing supramagnetic iron oxide particle nanometers, it can be utilized to visualize liver metastases and to differentiate intestinal loops from other abdominal structures.

3.Radioactive microspheres:

Radio embolization treatment microspheres are 10–30 nm larger than capillary diameters and are inserted into the first capillary a bed as they go by. In all of these situations, they are inserted into the arteries that lead to the A tumor of interest leading to increased radioactivity. microspheres to target regions without causing Injures the normal tissues that surround them. This differs from the medication delivery method in that radioactivity is not released from microspheres but rather functions from a distance characteristicOf a radioisotope, there are three kinds of Microspheres that are radioactive and emit α, β, and π particles.

4. Floating Microspheres:

Floating forms remain buoyant in the stomach without affecting the rate of gastric emptying because their bulk density is lower than That of the gastric fluid; as the body floats on stomach content and reduces gastric residency and plasma, the medication is progressively released at The required rate, changes in concentration. Additionally, this lessens the possibility of striking and dose dumping; in this way it reduces the frequency of dose is by producing a long-lasting therapeutic impact.

5. Polymeric microspheres:

Biodegradable and synthetic polymeric microspheres are the two categories into which the This material can be divided into different types.

6. Biodegradable polymeric microspheres:

Because they are inherently biodegradable, biocompatible, and even bioadhesive, natural polymers like starch are Were employed. This is due to their powerful swelling. capabilities with aqueous media, biodegradable polymers prolong their time in contact with the mucosal membrane. The Polymer concentration and release pattern sustainably control the rate and extent of The way the medication is released is the main drawback because controlling medication release and ensuring the dependability of biodegradable microspheres in Clinical settings are difficult. Nevertheless, they provide a broad range of microsphere-centered therapy applications.

7. Synthetic polymeric microspheres:

Although synthetic polymeric microspheres have been shown to be safe and biocompatible and are frequently employed in therapeutic applications as bulking agents, fillers, embolic particles, drug delivery vehicles, and similar items, their primary disadvantage is that they seem to move away from the injection site, which could cause injury, blood clot, and more organ damage.

Materials used in the microsphere formulation

Polymers are mostly employed in the creation of Microspheres are divided as outlined below.

A. Synthetic Polymers

They are divided into two categories.

Polymers which are not biodegradable Poly methyl methacrylate (PMMA), for instance, and acrolein Methacrylic acid, epoxy polymers Biodegradable materials Lactides, glycolides, and their co-polymers are a few examples. Poly anhydrides and polyalkyl cyano acrylates

B. Natural polymers

They come from a variety of sources, including Proteins, carbohydrates, and carbohydrates which have been chemically altered. Additionally, proteins including albumin, gelatin, and Collagen is used. Agarose, carrageenan, chitosan, starch, as well as chemically altered carbohydrates like poly dextran and poly starch, are Examples of common carbohydrates.[8,9, 10].

METHOD OF PREPARATION:

1. Solvent evaporation method:

a) Single emulsion technique: The microparticulate carriers of natural polymers which are proteins and carbohydrates are prepared by a single emulsion method (Rafiee & Abdul Rasool, 2022). The natural polymers are dissolved/dispersed in an aqueous Dispersion takes place in the non-aqueous medium, for example oil; the following step consists in carrying out the crosslinking of the dispersed globule. Either by means of heat or by using chemical cross-linking agents. The agents used in the chemical cross-linking process lauraldehyde, formaldehyde, terephthalate Chloride, dichloride. Cross-linking is done by means of heat. affected by adding the dispersion to previously oil that has been heated (Jin et al., 2018). It is not appropriate to use heat denaturation for the thermolabile drugs while the chemical crosslinking suffers the disadvantage of excessive exposure of active ingredient to chemicals if added at the time of preparation and then subjected to centrifugation, washing, and separation (Shivane et al., 2013).

Figure 1: Single Emulsion Technique

b) Double emulsion technique:

This process consumes the formation of the multiple emulsions or the double emulsion of type w/o/w and is best suited to the water-soluble drugs, peptides, proteins, and vaccines (Hema et al., 2022). The water-based protein solution is dispersed in a lipophilic organic continuous phase which is generally consisted of a polymer solution that eventually encapsulates The protein that is in the dispersed aqueous phase (Ramos et al., 2022) . The primary emulsion is then subjected to homogenization before addition to an aqueous solution of PVA; this causes the formation of double emulsion which is then subjected to solvent removal by solvent evaporation maintaining the emulsion at reduced pressure or by stirring so that The organic phase evaporates (Duong et al., 2020). Some examples are hydrophilic drugs like LHRH agonists, vaccines, and proteins. Fig No. 02: Double Emulsion Method (Deshmukh et al., 2025) .

Figure 2: Double Emulsion Technique

2. Coacervation phase separation method:

This method is used to prepare the reservoir type of the system to encapsulate water-soluble drugs Similar to peptides and proteins, it is the case with the matrix too (Klojdová et al., 2023) . For example, when the drug is hydrophobic, such as steroids (Nsairat et al., 2022). In a matrix-type device, the drug or the protein is It dissolves in the polymer phase; the process is based on the principle of decreasing the solubility of the polymer in the organic phase to affect the formation of the polymer-rich phase called the The concordats can be achieved (Deshmukh et al., 2025). by the addition of the third component to the system which results in the formation of the two phases, for example the supernatant, which is depleted of the polymer; in this method the polymer is first dissolved in a suitable solvent and then the drug is dispersed by making its aqueous solution, if hydrophilic or dissolved in the polymer solution itself, if hydrophobic (Makadia & Siegel, 2011a).

3.Spray drying and spray congealing: These methods rely on drying a mist composed of polymer and drug in air (Marante et al., 2020).Spray drying and spray congealing are two distinct processes, differing in whether the solvent is removed through evaporation or the solution is cooled to induce solidification (Bertoni et al., 2019).The polymer is initially dissolved in a suitable volatile organic solvent, such as dichloromethane or acetone, among others (Makadia & Siegel, 2011b).The drug is then incorporated into this solution (Ezike et al., 2023). The solid form is then dispersed in the polymer solution under high-speed homogenization (Giri et al., 2013). This dispersion is then atomized in a stream of hot air (Milanesi et al., 2025). The atomization leads to the formation of the small droplets or the fine mist from which the solvent evaporates instantaneously leading to the formation of the microspheres in a size range of 1- 100 μm (Karajagikar et al., 2025b). Microparticles are separated from the hot air using the cyclone separator while the traces of solvent are removed by vacuum drying (Karajagikar et al., 2025c).

4.Polymerization techniques: The polymerization techniques traditionally used for the preparation of microspheres are mainly classified as (Tanvi et al., 2025b): i) Normal polymerization: • It is carried out using different techniques such as bulk, suspension, precipitation, emulsion, and micellar polymerization processes (Saxena et al., 2021). • In bulk polymerization, a monomer or a mixture of monomers along with the initiator or catalyst is usually heated to start the polymerization process (Schmidt et al., 1985). • The polymer obtained can be shaped into microspheres; the drug loading can be done during the polymerization process (Saralidze et al., 2010c). Suspension polymerization, also known as bead or pearl polymerization, is carried out by heating the monomer or mixture of monomers as droplets dispersed in a continuous aqueous phase (Elbert, 2011). The droplets may also contain an initiator (Hu, n.d.) . Emulsion polymerization is different from suspension polymerization because the initiator is present in the aqueous phase, which later spreads to the surface of the micelles (Polymers, n.d.) . Bulk polymerization has the advantage of producing a pure polymer (Why Does Bulk Polymerization Produce Pure Polymers?, n.d.). ii) Interfacial polymerization: It involves the reaction of various monomers at the interface between two immiscible liquid phases to form a polymer film that essentially surrounds the dispersed phase (“Interfacial Polymerization,” 2026).

5.Solvent Extraction:

The solvent evaporation method is used for the The preparation of microparticles, this involving the removal of the organic phase by extraction of the An organic solvent; the method uses organic solvents that are miscible with water such as isopropanol (Jelvehgari & Montazam, 2012). Organic phases were removed by extraction with Water; this process reduces the hardening time (Krakowska-Sieprawska et al., 2022). Regarding the microspheres, one version of the process involves the direct addition of the drug or protein To the organic polymer solution, the rate of the solvent removal by extraction method depends on the temperature of the water, the ratio of emulsion volume to the water, and the solubility profile of the Polymer (Ahmad et al., 2022).

ADVANTAGES :

The therapeutic effect of microspheres is continuous and lasting. (Deshmukh et al., 2025) It reduces the number of doses, which enhances patient compliance.They were large enough to be inserted into The body was spherical in shape.The way in which the microspheres are arranged enables predictable fluctuations in medication release and breakdown.When the size is reduced, the surface area increases. area, which can improve a drug's poor solubility. (Particle Size Analysis and Reduction Techniques to Enhance Drug Bioavailability in Preclinical Studies - WuXi AppTec DMPK, n.d.) The distribution of drugs is at its highest when the drug is coated with polymers to prevent enzymatic cleavage. (Advances In pH-Triggered Polymers For Oral Drug Delivery: Design Strategies And Applications | IJSRT Journal, n.d.) Try to react less to the environment.With respect to the core. Reducing the size increases the surface area and can boost the effectiveness of the ingredient that isn't easily soluble. Exploring the chemical reactivity and functionalization of sericin for advanced applications (Aad et al., 2025)

DISADVANTAGES:

Microsphere formulations are designed to release the drug (Kim & Pack, 2006).Microsphere formulations also release the drug at different rates, depending upon several factors including food and how the drug enters the stomach (Shewale et al., 2024). Microsphere formulations may also release the drug at different rates from dose to dose (Tanvi et al., 2025a).

Since microsphere formulations contain a higher amount of the active ingredient than other formulations, if there is a problem with the way the formulation releases the active ingredient then this can lead to (Kircik, 2011). Hazardous conditions. It is prohibited to chew or crush microsphere formulations (Karajagikar et al., 2025a)

APPLICATIONS: 1.Regarding the use of microspheres in vaccine delivery: A vaccine’s main purpose is to protect against a microorganism or the harmful substances it produces (Vaccines: Inoculation, Immunization, Safety & Schedule, n.d.). An effective vaccine should fulfill important requirements such as being safe, effective, and easy to administer, especially in minimizing adverse reactions, which is a challenging task (K.B. et al., 2022).The vaccine’s safety profile and its ability to generate antibodies are closely connected to the method of administration (Zhang et al., 2015).Using biodegradable delivery systems for vaccines given through parenteral routes (such as subcutaneous, intramuscular, or intradermal injections) may help overcome some issues with traditional vaccines (Lin et al., 2015a).These methods offer several benefits, including: i) enhancing the antigenic response through the adjuvant effect, ii) enabling controlled release, and iii) stabilizing the antigen (Zhao et al., 2023). 2.Microspheres targeted using monoclonal antibodies: Microspheres that are directed to specific locations using monoclonal antibodies are known as immune-microspheres (Rembaum & Dreyer, 1980). This method helps to guide microspheres to targeted areas.Monoclonal antibodies are very specific molecules that can be used to deliver microspheres containing active substances to the desired site by attaching them covalently (Zhai et al., 2024).This attachment can be achieved through various surface groups such as aldehyde, amino, or hydroxyl groups on the microsphere surface (Chen et al., 2025) .There are several ways to link monoclonal antibodies to microspheres, including: i) non-specific adsorption, ii) specific adsorption, iii) direct coupling, and iv) the use of chemical reagents (Jafarzadeh Chehraghi et al., n.d.). 3.Oral drug delivery: The ability of polymer-based microspheres to form films makes them suitable for use in film dosage forms as an alternative to traditional pharmaceutical tablets ((PDF) APPLICATION OF MICROSPHERES IN PHARMACEUTICAL INDUSTRY, n.d.). Their sensitivity to pH, along with the reactivity of primary amine groups, increases their potential for oral drug delivery.Examples of such polymers are chitosan and gelatin (Mao et al., 2006). 4.Gene delivery: Microspheres can act as efficient oral carriers for genes due to their adhesion and transport properties in the gastrointestinal (GI) tract (Ganju et al., 2025). Materials used for this purpose include chitosan, gelatin, viral vectors, cationic liposome-polycation complexes, DNA plasmids, and insulin (Bolhassani et al., 2014).These microspheres are also beneficial in vaccine delivery, as vaccines aim to protect against microorganisms or their harmful byproducts.Biodegradable delivery systems for parenteral vaccines can help address some of the limitations of conventional vaccines (Lin et al., 2015b). 5.Drug delivery within a tumor and locally: To deliver paclitaxel at therapeutic levels to the tumor site, polymer-based films are used (Mahvi et al., 2023). A combination of drugs shows great promise for controlled delivery within the mouth.Examples of materials used for this purpose include gelatin, PLGA, and chitosan (Desai et al., 2023). 6.Ocular drug delivery: Drug-loaded ocular delivery systems are commonly used to treat glaucoma, especially for cholinergic agonists like pilocarpine (Peter & Panonnummal, 2021). The short half-life of aqueous eye drops, usually between 1 to 3 minutes, can be extended to 15 to 20 minutes by using microspheres made from biodegradable materials, such as polyalkylcyanoacrylate (Renner et al., 2007). 7.Nasal drug delivery: Polymer-based drug delivery systems, including microspheres, liposomes, and gels, have good adhesion properties (Sriwidodo et al., 2022). When these systems come into contact with the nasal mucosa, they tend to swell, which improves drug bioavailability and increases the time the drug remains in the nasal area (Türker et al., 2004).Examples of the polymers used are starch, dextran, and albumin (Why Does Bulk Polymerization Produce Pure Polymers?, n.d.).Top of Form

8.Gastrointestinal drug delivery: Polymer granules with internal cavities, formed through deacidification, become buoyant in acidic or neutral environments, enabling controlled release of drugs (Binauld & Stenzel, 2013). For instance, hollow microcapsules containing melatonin float in the gastrointestinal tract, demonstrating a gastroretentive controlled-release system (Maghsoodi et al., 2011).The release of the drug is significantly slowed, taking between 1.75 and 6.7 hours in simulated gastric fluid (Nabais & Leclair, 2014).These microcapsules remain in the stomach for more than ten hours (Bhadouriya et al., 2012).Examples include chitosan microspheres loaded with Metoclopramide and Glipizide (Ganza-González et al., 1999). 9.Buccal drug delivery: Chitosan is a suitable polymer for buccal drug delivery because of its mucosal and bioadhesive properties, as well as its ability to enhance drug absorption (M. Ways et al., 2018).(Chaudhari et al., 2025).

Even polymer microparticles without any drug incorporated still exhibit antimicrobial properties due to the nature of the polymer itself (Alkarri et al., 2024).Buccal bilayer devices, such as bilaminated films or layered tablets, which combine drugs like Nifedipine and Propranolol hydrochloride along with chitosan, either with or without anionic crosslinking polymers (such as polycarbophil, sodium alginate, or gellan gum), show great potential for controlled drug delivery in the mouth (Patel et al., 2007). 10.Vaginal drug delivery: The polymer, modified by adding thioglycolic acid to its primary amino groups, incorporates Clotrimazole, an imidazole derivative commonly used for treating fungal infections of the genitourinary tract (Grimling et al., 2020). The introduction of thiol groups enhances the mucoadhesive properties of polymer-based drug delivery systems, such as Microspheres, liposomes, and gels—all of these systems show strong bioadhesive characteristics, allowing them to swell upon contact with the nasal mucosa, which improves the bioavailability and extends the residence time of drugs given by the nasal [route. Examples of such Starch, dextran, and albumin are all examples of polymers (Puri et al., 2020).

11.Transdermal drug delivery:

The polymer has very good film-forming properties (Mundada et al., 2011). The drug release from these devices is influenced by factors For example, the thickness of the membrane and the extent of crosslinking of the film (Langner et al., 2024). A chitosan-alginate polyelectrolyte complex has been developed in situ into beads and microspheres for use in various applications, including controlled release systems, packaging, and wound Dressings (Yan et al., 2000). Polymer gel beads show promise biocompatible and biodegradable carriers for treating local inflammation, with drugs like Prednisolone showing With a sustained release and improved therapeutic effects (Khaled et al., 2010). The rate of drug release depends on the type of membrane A combination involving chitosan membranes and chitosan was used (Stefanache et al., 2025). hydrogel, incorporating lidocaine hydrochloride (a local anesthetic), forms an effective transparent system for involving the controlled delivery of drugs and optimal kinetics of release (Jeong et al., 2025).

Figure 3: Polymerization Technique

Bottom of Form

CONCLUSION:

When compared with a great many other methods of drug delivery, microspheres represent a better choice. By combining a variety of different techniques, they are likely to take on a key role in new drug delivery systems, particularly in the sorting of diseased cells, in diagnostics, in the delivery of genes and genetic material, and in providing safe, targeted, specific and efficient in vitro delivery, as well as in supplements which act as small replicas of the body's diseased organs and tissues. Compared with existing technology, microspheres have a number of advantages and have therefore become an exciting new platform for biologists to use when investigating the relationships between biomolecules.

There are numerous applications of microspheres, and in recent years they have been used in an increasing number of research projects for a wide range of purposes. It is evident that their potential is great. They have been put to use in studies relating to pulmonary perfusion and inhalation, as well as in scanning the liver, the brain, the heart, and the gastrointestinal tract. Even though the term 'microsphere' is short, it has a number of applications in drug delivery systems in order to produce the desired biological activity. By combining various methods such as cell sorting, genetic engineering, and diagnostics, microspheres will play a key role in innovative drug delivery systems. The study shows that the new medication delivery system functions well when microspheres are used as carriers.

Microspheres are a short-term approach but are used in a wide range of applications in pharmaceutical delivery systems. Some of the important applications are targeted drug delivery (bio-adhesive microspheres for nasal, ocular, buccal, rectal routes, magnetic and radioactive microspheres for tumours), controlled and sustained release (polymeric and floating microspheres). Microspheres will be the heart of new systems for drug delivery by combining different approaches, especially for cell sorting, diagnostics and genetic engineering. The results of this study demonstrate that microspheres can function as effective carriers for novel systems for drug delivery.

REFERENCES

1. Aad, R., Leuzzi, L., Mandelli, S., Cipolla, L., & Vesentini, S. (2025). Exploring the chemical reactivity and functionalization of sericin for advanced applications. Next Materials, 9, 101289. https://doi.org/10.1016/j.nxmate.2025.101289
2. Adepu, S., & Ramakrishna, S. (2021a). Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules, 26(19), 5905. https://doi.org/10.3390/molecules26195905
3. Adepu, S., & Ramakrishna, S. (2021b). Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules, 26(19), 5905. https://doi.org/10.3390/molecules26195905
4. Advances In pH-Triggered Polymers For Oral Drug Delivery: Design Strategies And Applications | IJSRT Journal. (n.d.). Retrieved October 13, 2026, from https://www.ijsrtjournal.com/article/advances-in-ph-triggered-polymers-for-oral-drug-delivery-design-strategies-and-applications
5. Ahmad, W., Quazi, J., Khan, R., Ahmad, N., & Ansari, N. (2022). A Comprehensive Review on Microspheres. Asian Journal of Pharmacy and Technology, 12(2), 136–140. https://doi.org/10.52711/2231-5713.2022.00023
6. Alkarri, S., Bin Saad, H., & Soliman, M. (2024). On Antimicrobial Polymers: Development, Mechanism of Action, International Testing Procedures, and Applications. Polymers, 16(6), 771. https://doi.org/10.3390/polym16060771
7. Aqueel, S., Sakarkar, D. M., Misal, R. B., Mohare, Y., & Hattiambire, K. (n.d.). Bioadhesive Microspheres As A Controlled Drug Delivery System: A Review.
8. Bertoni, S., Albertini, B., & Passerini, N. (2019). Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs. Molecules, 24(19), 3471. https://doi.org/10.3390/molecules24193471
9. Bhadouriya, P., Kumar, M., & Pathak, K. (2012). Floating microspheres: To prolong the gastric retention time in stomach. Current Drug Delivery, 9(3), 315–324. https://doi.org/10.2174/156720112800389061
10. BHISE, M., SHUKLA, K., JAIN, S., BHAJIPALE, N., SUDKE, S., & BURAKLE, P. (2022). Development and Evaluation of Floating Microspheres of Anticonvulsant Drug by 32 Full Factorial Design. Turkish Journal of Pharmaceutical Sciences, 19(5), 595–602. https://doi.org/10.4274/tjps.galenos.2021.53050
11. Binauld, S., & Stenzel, M. H. (2013). Acid-degradable polymers for drug delivery: A decade of innovation. Chemical Communications, 49(21), 2082–2102. https://doi.org/10.1039/c2cc36589h
12. Bolhassani, A., Javanzad, S., Saleh, T., Hashemi, M., Aghasadeghi, M. R., & Sadat, S. M. (2014). Polymeric nanoparticles. Human Vaccines & Immunotherapeutics, 10(2), 321–332. https://doi.org/10.4161/hv.26796
13. Chaudhari, K., Dhankani, M., Dhankani, A., & Pawar, S. (2025). Microspheres: Key Players in Targeted Drug Delivery and Controlled Release. International Journal of Pharmaceutical Sciences, 03(03), 2207–2216. (World). https://doi.org/10.5281/zenodo.15079731
14. Chauhan, Y. S., Nex, R., Sevak, G., & Rathore, M. S. (2021). Stability Testing of Pharmaceutical Products. Research Journal of Pharmaceutical Dosage Forms and Technology, 13(4), 317–328. https://doi.org/10.52711/0975-4377.2021.00052
15. Chen, Y., Chen, Z., Lei, K., Ding, J., & Yu, L. (2025). Surface modification of polyetheretherketone for boosted osseointegration: A review. Biomaterials Translational, 6(2), 181–201. https://doi.org/10.12336/bmt.24.00052
16. Chu, J. N., & Traverso, G. (2022). Foundations of gastrointestinal-based drug delivery and future developments. Nature Reviews. Gastroenterology & Hepatology, 19(4), 219–238. https://doi.org/10.1038/s41575-021-00539-w
17. Desai, N., Rana, D., Salave, S., Gupta, R., Patel, P., Karunakaran, B., Sharma, A., Giri, J., Benival, D., & Kommineni, N. (2023). Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications. Pharmaceutics, 15(4), 1313. https://doi.org/10.3390/pharmaceutics15041313
18. Deshmukh, M., Rakshe, V., Shelke, P., Phule, S., Asawale, S., & Panmand, P. (2025). Review on Microspheres. International Journal of Pharmaceutical Sciences, 03(10), 341–351. (World). https://doi.org/10.5281/zenodo.17515499
19. Dobrotă, D., Bărbușiu, A.-M., Sava, G.-A., & Oleksik, V. Ștefan. (2025). Functional Additives in Automotive Polymer Matrices: Compatibility, Mechanisms, and Industry Challenges. Polymers, 17(17), 2328. https://doi.org/10.3390/polym17172328
20. Duong, V.-A., Nguyen, T.-T.-L., & Maeng, H.-J. (2020). Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method. Molecules, 25(20), 4781. https://doi.org/10.3390/molecules25204781
21. Elbert, D. L. (2011). Liquid-liquid two phase systems for the production of porous hydrogels and hydrogel microspheres for biomedical applications: A tutorial review. Acta Biomaterialia, 7(1), 31–56. https://doi.org/10.1016/j.actbio.2010.07.028
22. Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., Nwadike, U. G., Ogbodo, J. O., Umeh, B. U., Ossai, E. C., & Nwanguma, B. C. (2023). Advances in drug delivery systems, challenges and future directions. Heliyon, 9(6), e17488. https://doi.org/10.1016/j.heliyon.2023.e17488
23. GALASKA, R., & RICHEY, T. (2022). Methods and systems for making polymer microspheres (World Intellectual Property Organization Patent No. WO2022192838A1). https://patents.google.com/patent/WO2022192838A1/en
24. Ganju, E., Shama, S., Dubey, R., & Gupta, B. K. (2025). Microspheres as Novel Drug Delivery Advantages and Application: A Review. International Journal of Pharmaceutical Sciences, 03(04), 1525–1535. (World). https://doi.org/10.5281/zenodo.15202876
25. Ganza-González, A., Anguiano-Igea, S., Otero-Espinar, F. J., & Blanco Méndez, J. (1999). Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 48(2), 149–155. https://doi.org/10.1016/s0939-6411 (99)00040-5
26. Giri, T. K., Choudhary, C., Ajazuddin, Alexander, A., Badwaik, H., & Tripathi, D. K. (2013). Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery. Saudi Pharmaceutical Journal : SPJ, 21(2), 125–141. https://doi.org/10.1016/j.jsps.2012.05.009
27. Goyal, R. K., Guo, Y., & Mashimo, H. (2019). Advances in the physiology of gastric emptying. Neurogastroenterology and Motility, 31(4), e13546. https://doi.org/10.1111/nmo.13546
28. Grimling, B., Karolewicz, B., Nawrot, U., Włodarczyk, K., & Górniak, A. (2020). Physicochemical and Antifungal Properties of Clotrimazole in Combination with High-Molecular Weight Chitosan as a Multifunctional Excipient. Marine Drugs, 18(12), 591. https://doi.org/10.3390/md18120591
29. Hema, S. K., Karmakar, A., Das, R. K., & Srivastava, P. (2022). Simple formulation and characterization of double emulsion variant designed to carry three bioactive agents. Heliyon, 8(9), e10397. https://doi.org/10.1016/j.heliyon.2022.e10397
30. Hu, Y. (n.d.). Controlled evaporation-induced phase separation of droplets containing nanogels and salt molecules. RSC Advances, 12(43), 27977–27986. https://doi.org/10.1039/d2ra04585k
31. Hussain, M., Khan, S. M., Shafiq, M., Abbas, N., Sajjad, U., & Hamid, K. (2024). Advances in biodegradable materials: Degradation mechanisms, mechanical properties, and biocompatibility for orthopedic applications. Heliyon, 10(12), e32713. https://doi.org/10.1016/j.heliyon.2024.e32713
32. Interfacial polymerization. (2026). In Wikipedia. https://en.wikipedia.org/w/index.php?title=Interfacial_polymerization&oldid=1352522127
33. Jafarzadeh Chehraghi, E., Akbarzadehlaleh, P., & Shamsasenjan, K. (n.d.). Purification of Monoclonal Antibodies Using Chromatographic Methods: Increasing Purity and Recovery. Advanced Pharmaceutical Bulletin, 15(1), 27–45. https://doi.org/10.34172/apb.43967
34. Jelvehgari, M., & Montazam, S. H. (2012). Comparison of Microencapsulation by Emulsion-Solvent Extraction/Evaporation Technique Using Derivatives Cellulose and Acrylate-Methacrylate Copolymer as Carriers. Jundishapur Journal of Natural Pharmaceutical Products, 7(4), 144–152.
35. Jeong, J.-O., Kim, M., Kim, S., Lee, K. K., & Choi, H. (2025). Advanced Hydrogel Systems for Local Anesthetic Delivery: Toward Prolonged and Targeted Pain Relief. Gels, 11(2), 131. https://doi.org/10.3390/gels11020131
36. Jin, X., Li, L., Xu, R., Liu, Q., Ding, L., Pan, Y., Wang, C., Hung, W., Lee, K., & Wang, T. (2018). Effects of Thermal Cross-Linking on the Structure and Property of Asymmetric Membrane Prepared from the Polyacrylonitrile. Polymers, 10(5), 539. https://doi.org/10.3390/polym10050539
37. Karajagikar, T., Panchal, A., & Madankar, V. (2025a). Microsphere as Novel Drug Delivery System. International Journal of Scientific Research and Technology, 03(02), 65–69. (World). https://doi.org/10.5281/zenodo.14836892
38. Karajagikar, T., Panchal, A., & Madankar, V. (2025b). Microsphere as Novel Drug Delivery System. International Journal of Scientific Research and Technology, 03(02), 65–69. (World). https://doi.org/10.5281/zenodo.14836892
39. Karajagikar, T., Panchal, A., & Madankar, V. (2025c). Microsphere as Novel Drug Delivery System. International Journal of Scientific Research and Technology, 03(02), 65–69. (World). https://doi.org/10.5281/zenodo.14836892
40. K.B., M., Nayar, S. A., & P.V., M. (2022). Vaccine and vaccination as a part of human life: In view of COVID‐19. Biotechnology Journal, 17(1), 2100188. https://doi.org/10.1002/biot.202100188
41. Khaled, K. A., Sarhan, H. A., Ibrahim, M. A., Ali, A. H., & Naguib, Y. W. (2010). Prednisolone-Loaded PLGA Microspheres. In Vitro Characterization and In Vivo Application in Adjuvant-Induced Arthritis in Mice. AAPS PharmSciTech, 11(2), 859–869. https://doi.org/10.1208/s12249-010-9445-5
42. Kim, K. K., & Pack, D. W. (2006). Microspheres for Drug Delivery. BioMEMS and Biomedical Nanotechnology, 19–50. https://doi.org/10.1007/978-0-387-25842-3_2
43. Kircik, L. H. (2011). Microsphere Technology. The Journal of Clinical and Aesthetic Dermatology, 4(5), 27–31.
44. Klojdová, I., Milota, T., Smetanová, J., & Stathopoulos, C. (2023). Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds? Pharmaceuticals, 16(3), 362. https://doi.org/10.3390/ph16030362
45. Krakowska-Sieprawska, A., Kiełbasa, A., Rafińska, K., Ligor, M., & Buszewski, B. (2022). Modern Methods of Pre-Treatment of Plant Material for the Extraction of Bioactive Compounds. Molecules, 27(3), 730. https://doi.org/10.3390/molecules27030730
46. Langner, M., Priese, F., & Wolf, B. (2024). Influence of Polymer Film Thickness on Drug Release from Fluidized Bed Coated Pellets and Intended Process and Product Control. Pharmaceutics, 16(10), 1307. https://doi.org/10.3390/pharmaceutics16101307
47. Lin, C.-Y., Lin, S.-J., Yang, Y.-C., Wang, D.-Y., Cheng, H.-F., & Yeh, M.-K. (2015a). Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases. Human Vaccines & Immunotherapeutics, 11(3), 650–656. https://doi.org/10.1080/21645515.2015.1009345
48. Lin, C.-Y., Lin, S.-J., Yang, Y.-C., Wang, D.-Y., Cheng, H.-F., & Yeh, M.-K. (2015b). Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases. Human Vaccines & Immunotherapeutics, 11(3), 650–656. https://doi.org/10.1080/21645515.2015.1009345
49. M. Ways, T. M., Lau, W. M., & Khutoryanskiy, V. V. (2018). Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems. Polymers, 10(3), 267. https://doi.org/10.3390/polym10030267
50. Maghsoodi, M., Hemati, E., Qadermazi, B., & Yari, Z. (2011). Hollow microspheres for gastroretentive floating- pulsatile drug delivery: Preparation and in vitro evaluation. Advanced Pharmaceutical Bulletin, 1(2), 55–61. https://doi.org/10.5681/apb.2011.008
51. Mahvi, D. A., Korunes-Miller, J., Bordeianu, C., Chu, N.-Q., Geller, A. D., Sabatelle, R., Berry, S., Hung, Y. P., Colson, Y. L., Grinstaff, M. W., & Raut, C. P. (2023). High dose, dual-release polymeric films for extended surgical bed paclitaxel delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society, 363, 682–691. https://doi.org/10.1016/j.jconrel.2023.09.048
52. Makadia, H. K., & Siegel, S. J. (2011a). Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers, 3(3), 1377–1397. https://doi.org/10.3390/polym3031377
53. Makadia, H. K., & Siegel, S. J. (2011b). Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers, 3(3), 1377–1397. https://doi.org/10.3390/polym3031377
54. Mao, J., Kondu, S., Ji, H.-F., & McShane, M. J. (2006). Study of the Near-Neutral pH-Sensitivity of Chitosan/Gelatin Hydrogels by Turbidimetry and Microcantilever Deflection. Biotechnology and Bioengineering, 95(3), 333–341. https://doi.org/10.1002/bit.20755
55. Marante, T., Viegas, C., Duarte, I., Macedo, A. S., & Fonte, P. (2020). An Overview on Spray-Drying of Protein-Loaded Polymeric Nanoparticles for Dry Powder Inhalation. Pharmaceutics, 12(11), 1032. https://doi.org/10.3390/pharmaceutics12111032
56. Milanesi, A., Diana, G., Candiani, A., Sodano, A., Rassè, P., Foglio Bonda, A., Bari, E., Torre, M. L., Segale, L., & Giovannelli, L. (2025). Spray drying: From a traditional technology to modern biotechnological applications. International Journal of Pharmaceutics: X, 10, 100449. https://doi.org/10.1016/j.ijpx.2025.100449
57. Moritera, T., Ogura, Y., Honda, Y., Wada, R., Hyon, S. H., & Ikada, Y. (1991). Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. Investigative Ophthalmology & Visual Science, 32(6), 1785–1790.
58. Mundada, A., Satturwar, P., Fulzele, S., Joshi, S., & Dorle, A. (2011). Characterization and Evaluation of Novel Film Forming Polymer for Drug Delivery. Iranian Journal of Pharmaceutical Research : IJPR, 10(1), 35–42.
59. N, M. B., R, N., N, S. H., & Joshi, H. K. (2026). Magnetic Microspheres as Targeted Drug Delivery Systems: An Overview of Design and Therapeutic Applications. International Journal of Pharmaceutical Sciences, 04(04), 4987–4999. (World). https://doi.org/10.5281/zenodo.19919627
60. Nabais, T., & Leclair, G. (2014). High-Amylose Sodium Carboxymethyl Starch Matrices: Development and Characterization of Tramadol Hydrochloride Sustained-Release Tablets for Oral Administration. ISRN Pharmaceutics, 2014, 391523. https://doi.org/10.1155/2014/391523
61. Namdev, A., & Jain, D. (2019). Floating Drug Delivery Systems: An Emerging Trend for the Treatment of Peptic Ulcer. Current Drug Delivery, 16(10), 874–886. https://doi.org/10.2174/1567201816666191018163519
62. Noguez Méndez, N. A., Quirino Barreda, C. T., Vega, A. F., Miranda Calderon, J. E., Urioste, C. G., Palomec, X. C., Martínez, A. R., & Díaz, M. P. (2017). Chapter 22—Design and development of pharmaceutical microprocesses in the production of nanomedicine. In E. Andronescu & A. M. Grumezescu (Eds.), Nanostructures for Oral Medicine (pp. 669–697). Elsevier. https://doi.org/10.1016/B978-0-323-47720-8.00023-7
63. Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022). Liposomes: Structure, composition, types, and clinical applications. Heliyon, 8(5), e09394. https://doi.org/10.1016/j.heliyon.2022.e09394
64. Particle Size Analysis and Reduction Techniques to Enhance Drug Bioavailability in Preclinical Studies—WuXi AppTec DMPK. (n.d.). Retrieved October 13, 2026, from https://dmpkservice.wuxiapptec.com/articles/457-particle-size-analysis-and-reduction-techniques-to-enhance-drug-bioavailability-in-preclinical-studies/
65. Patel, V. M., Prajapati, B. G., & Patel, M. M. (2007). Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech, 8(1), E147–E154. https://doi.org/10.1208/pt0801022
66. (PDF) APPLICATION OF MICROSPHERES IN PHARMACEUTICAL INDUSTRY. (n.d.). ResearchGate. https://doi.org/10.37896/JBSV22.12/1609
67. Peter, M., & Panonnummal, R. (2021). A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma. Advanced Pharmaceutical Bulletin, 11(3), 399–413. https://doi.org/10.34172/apb.2021.048
68. Polymers, M. C. (n.d.). Emulsion vs Solution Polymers: Key Differences. Retrieved October 15, 2026, from https://www.mcpolymers.com/library/the-difference-between-emulsion-polymers-and-solution-polymers
69. Procopio, A., Lagreca, E., Jamaledin, R., La Manna, S., Corrado, B., Di Natale, C., & Onesto, V. (2022). Recent Fabrication Methods to Produce Polymer-Based Drug Delivery Matrices (Experimental and In Silico Approaches). Pharmaceutics, 14(4), 872. https://doi.org/10.3390/pharmaceutics14040872
70. Puri, V., Sharma, A., Kumar, P., & Singh, I. (2020). Thiolation of Biopolymers for Developing Drug Delivery Systems with Enhanced Mechanical and Mucoadhesive Properties: A Review. Polymers, 12(8), 1803. https://doi.org/10.3390/polym12081803
71. Rafiee, M. H., & Abdul Rasool, B. K. (2022). An Overview of Microparticulate Drug Delivery System and its Extensive Therapeutic Applications in Diabetes. Advanced Pharmaceutical Bulletin, 12(4), 730–746. https://doi.org/10.34172/apb.2022.075
72. Ramos, R., Bernard, J., Ganachaud, F., & Miserez, A. (2022). Protein‐Based Encapsulation Strategies: Toward Micro‐ and Nanoscale Carriers with Increased Functionality. Small Science, 2(3), 2100095. https://doi.org/10.1002/smsc.202100095
73. Ravindra, N., R, N., V, N. V., Venkatesh, & K, H. J. (2026). Microspheres As Targeted Drug Delivery Systems: A Review. International Journal of Pharmaceutical Sciences, 04(04), 3389–3410. (World). https://doi.org/10.5281/zenodo.19676753
74. Rembaum, A., & Dreyer, W. J. (1980). Immunomicrospheres: Reagents for cell labeling and separation. Science, 208(4442), 364–368. https://doi.org/10.1126/science.6768131
75. Renner, W., Bachmann, M., Cielens, I., Coester, C., Dietmeier, K., Fuchs, S., Manolova, V., Maurer, P., Pumpens, P., Renhofa, R., Tissot, A., & Zou, Y. (2007). Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity (United States Patent No. US20070184068A1). https://patents.google.com/patent/US20070184068A1/en
76. Saralidze, K., Koole, L. H., & Knetsch, M. L. W. (2010a). Polymeric Microspheres for Medical Applications. Materials, 3(6), 3537–3564. https://doi.org/10.3390/ma3063537
77. Saralidze, K., Koole, L. H., & Knetsch, M. L. W. (2010b). Polymeric Microspheres for Medical Applications. Materials, 3(6), 3537–3564. https://doi.org/10.3390/ma3063537
78. Saralidze, K., Koole, L. H., & Knetsch, M. L. W. (2010c). Polymeric Microspheres for Medical Applications. Materials, 3(6), 3537–3564. https://doi.org/10.3390/ma3063537
79. Saxena, A. K., Sharma, A., & Verma, N. (2021). Microspheres as Therapeutically effective Multiparticulate Drug Delivery System: A Systemic Review. Research Journal of Pharmacy and Technology, 14(6), 3461–3470. https://doi.org/10.52711/0974-360X.2021.00602
80. Schmidt, R. E., Schultz, H. H., & Wilson, D. M. (1985). Bulk polymerization process for preparing high solids and uniform copolymers (United States Patent No. US4529787A). https://patents.google.com/patent/US4529787A/en
81. Shewale, B., Bhavsar, S., Talele, D. G., & Bhamre, J. (2024). Overview of Microspheres: An Advanced Drug Delivery System. International Journal of Pharmaceutical Sciences, 02(07), 2300–2309. (World). https://doi.org/10.5281/zenodo.13142952
82. Shivane, P., Sridevi, G., Gopkumar, P., & Pillai, S. (2013). Formulation and Evaluation of Sustain Release Microsphere of Tretinoin for the Treatment of Acne vulgarise. Research Journal of Pharmacy and Technology, 6(10), 1089–1093.
83. Sinha, V. R., Goyel, V., & Trehan, A. (2004). Radioactive microspheres in therapeutics. Die Pharmazie, 59(6), 419–426.
84. Sriwidodo, Umar, Abd. K., Wathoni, N., Zothantluanga, J. H., Das, S., & Luckanagul, J. A. (2022). Liposome-polymer complex for drug delivery system and vaccine stabilization. Heliyon, 8(2), e08934. https://doi.org/10.1016/j.heliyon.2022.e08934
85. Stefanache, A., Lungu, I. I., Anton, N., Damir, D., Gutu, C., Olaru, I., Plesea Condratovici, A., Duceac (Covrig), M., Constantin, M., Calin, G., Duceac, L. D., & Boev, M. (2025). Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives. Polymers, 17(11), 1453. https://doi.org/10.3390/polym17111453
86. Tanvi, R., Pratiksha, P., Daingade, P., & Shelke, T. T. (2025a). A Review of Microspheres: Types, Formulation Techniques, Characterization and Application. International Journal of Pharmaceutical Sciences, 03(09), 350–366. (World). https://doi.org/10.5281/zenodo.17264164
87. Tanvi, R., Pratiksha, P., Daingade, P., & Shelke, T. T. (2025b). A Review of Microspheres: Types, Formulation Techniques, Characterization and Application. International Journal of Pharmaceutical Sciences, 03(09), 350–366. (World). https://doi.org/10.5281/zenodo.17264164
88. Türker, S., Onur, E., & Ozer, Y. (2004). Nasal route and drug delivery systems. Pharmacy World & Science: PWS, 26(3), 137–142. https://doi.org/10.1023/b:phar.0000026823.82950.ff
89. Vaccines: Inoculation, Immunization, Safety & Schedule. (n.d.). Retrieved October 15, 2026, from https://my.clevelandclinic.org/health/treatments/24135-vaccines
90. Wang, M., Wang, S., Zhang, C., Ma, M., Yan, B., Hu, X., Shao, T., Piao, Y., Jin, L., & Gao, J. (2024). Microstructure Formation and Characterization of Long-Acting Injectable Microspheres: The Gateway to Fully Controlled Drug Release Pattern. International Journal of Nanomedicine, 19, 1571–1595. https://doi.org/10.2147/IJN.S445269
91. Why does bulk polymerization produce pure polymers? - ECHEMI.com. (n.d.). ECHEMI. Retrieved October 15, 2026, from https://www.echemi.com/community/why-does-bulk-polymerization-produce-pure-polymers_mjart2204121342_264.html
92. Yan, X., Khor, E., & Lim, L. Y. (2000). PEC films prepared from Chitosan-Alginate coacervates. Chemical & Pharmaceutical Bulletin, 48(7), 941–946. https://doi.org/10.1248/cpb.48.941
93. Zhai, M., Wu, P., Liao, Y., Wu, L., & Zhao, Y. (2024). Polymer Microspheres and Their Application in Cancer Diagnosis and Treatment. International Journal of Molecular Sciences, 25(12), 6556. https://doi.org/10.3390/ijms25126556
94. Zhang, L., Wang, W., & Wang, S. (2015). Effect of Vaccine Administration Modality on Immunogenicity and Efficacy. Expert Review of Vaccines, 14(11), 1509–1523. https://doi.org/10.1586/14760584.2015.1081067
95. Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023). Vaccine adjuvants: Mechanisms and platforms. Signal Transduction and Targeted Therapy, 8, 283. https://doi.org/10.1038/s41392-023-01557-7